Physiologically-based pharmacokinetic modeling of nafamostat to support dose selection for treatment of pediatric patients with COVID-19-Reference-Cited by-同舟云学术

Physiologically-based pharmacokinetic modeling of nafamostat to support dose selection for treatment of pediatric patients with COVID-19

Published:2022 Issue:1 Volume:30 Page:24
ISSN:2289-0882
Container-title:Translational and Clinical Pharmacology
language:en
Short-container-title:Transl Clin Pharmacol

Author:

Cho Yong-Soon¹²^ORCID,Shin Jae-Gook¹²^ORCID

Affiliation:

1. Center for Personalized Precision Medicine of Tuberculosis (cPMTb), Inje University College of Medicine, Busan 47392, Korea.

2. Department of Pharmacology and Clinical Pharmacology, PharmacoGenomics Research Center, Inje University College of Medicine, Busan 47392, Korea.

Funder

National Research Foundation of Korea

Publisher

Korean Society for Clinical Pharmacology and Therapeutics

Subject

Pharmacology (medical)

Link

https://tcpharm.org/pdf/10.12793/tcp.2022.30.e4

Reference54 articles.

1. COVID-19 in Children: An Epidemiology Study from China

2. Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19) [Internet]. Accessed February 5, 2022. https://emergency.cdc.gov/han/2020/han00432.asp

3. Hyperinflammatory shock in children during COVID-19 pandemic

4. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

5. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically Based Pharmacokinetic Modeling in Neonates: Current Status and Future Perspectives;Pharmaceutics;2023-12-12

2. Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia;International Journal of Infectious Diseases;2023-03

3. Predicting the correct dose in children: Role of computational Pediatric Physiological‐based pharmacokinetics modeling tools;CPT: Pharmacometrics & Systems Pharmacology;2022-11-20